Loading...
Dernières publications
-
Liem Nguyen, Maud Lemoine, Gibril Ndow, Zachary Ward, Timothy Hallet, et al.. Treat All versus targeted strategies to select HBV-infected people for antiviral therapy in The Gambia, west Africa: a cost-effectiveness analysis. The Lancet global health, 2024, 12 (1), pp.e66-e78. ⟨10.1016/S2214-109X(23)00467-9⟩. ⟨pasteur-04363873⟩
-
Luc Jaulmes, Youri Yordanov, Alexandre Descamps, Isabelle Durand-Zaleski, Aurélien Dinh, et al.. Effectiveness and Medicoeconomic Evaluation of Home Monitoring of Patients With Mild COVID-19: Covidom Cohort Study. Journal of Medical Internet Research, 2023, 25, pp.e43980. ⟨10.2196/43980⟩. ⟨hal-04142340⟩
-
Christiana Kartsonaki, J Kenneth Baillie, Noelia García Barrio, Joaquín Baruch, Abigail Beane, et al.. Characteristics and outcomes of an international cohort of 600 000 hospitalized patients with COVID-19. International Journal of Epidemiology, 2023, 52 (2), pp.355-376. ⟨10.1093/ije/dyad012⟩. ⟨hal-04164628⟩
-
Paul Loubet, Linda Wittkop, Laetitia Ninove, Mathieu Chalouni, Benoit Barrou, et al.. One-month humoral response following two or three doses of mRNA Covid-19 vaccines as primary vaccination in specific populations in France: first results from the ANRS0001S COV-POPART cohort. Clinical Microbiology and Infection, 2023, 29 (3), pp.388.e1-388.e8. ⟨10.1016/j.cmi.2022.10.009⟩. ⟨hal-03822592⟩
-
Jade Ghosn, Delphine Bachelet, Marine Livrozet, Minerva Cervantes-Gonzalez, Julien Poissy, et al.. Prevalence of Post-Acute COVID-19 Symptoms Twelve Months after Hospitalisation in Participants Retained in Follow-up: Analyses Stratified by Gender from a Large Prospective Cohort. Clinical Microbiology and Infection, 2023, 29 (2), pp.254.e7-254.e13. ⟨10.1016/j.cmi.2022.08.028⟩. ⟨hal-03801797⟩
Le CIC-1417 sur Twitter
Documents en texte intégral
70
Notices
67
Mots clés
Epidemiology
Vaccine effectiveness
C-type lectin receptor
Covidom
AstraZeneca vaccine
Antiviral therapy
EHealth literacy
Coadministration
Cancer
Immunization
Chemotherapy
COVID-19 vaccines
Vaccine
Influenza
AIDS
Innate immunity
Determinant
Digital health intervention
Vaccines
Booster response
Conjugate pneumococcal vaccine
Coronavirus
Attitudes of health personnel
Vaccine safety and efficacy
Respiratory syncytial virus
Adenoviral vector
Alpha variant
Misinformation
CERVICOVAGINAL SECRETIONS
Sleep
Delphi study
Vaccine hesitancy
Cost of illness
Awareness
Catch-up
Internet
Efficacy
AON
Drug
Digital care
Vaccine acceptance
Antiretroviral therapy
Cohort study
Antiviral
B-lymphocytes
Deletion
Hesitancy
1790GAHB F
Influenza-like illness
Adjuvant
Clinical practice
Attitude to health
Dose escalation
Chronic kidney disease
COCONEL cohort surveys
Practices
COVID-19
Incidence
Elderly
Acute kidney injury
HPV vaccine
Adults
Attitude
Determinants
Antiviral agents
Diabetes mellitus type 2
Data sharing
Assay
Co-morbidities
Care management
Adverse effects
Vaccination
Cystic fibrosis
Covid 19
Calcium phosphorus evaluation
Biomarkers
Immunocompromised
Disinformation
Cohort
DMD
Dendritic cells
Confidence
Déterminants
Attitudes
Risk factors
Boys
Immunogenicity
France
Clinical research
Conditional marketing authorization
EMA
Healthcare workers
Dialysis
Clinical trials
Covid-19
ANTIRETROVIRAL THERAPY
Effectiveness
HIV
SARS-CoV-2
Clinical skills